Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892586) titled 'Low-Dose Norepinephrine With Conservative Fluid Therapy in Hepatobiliary Surgery' on Oct. 18.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Assiut University
Condition:
Postoperative Complications
Pulmonary Complication
Intervention:
Other: Conventional Fluid Therapy
Drug: Low-Dose Norepinephrine
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 20, 2026
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/study/NCT07892586...